Twohig, H ORCID: https://orcid.org/0000-0001-8781-1268, Owen, C, Muller, S ORCID: https://orcid.org/0000-0001-6645-5751, Mallen, CD ORCID: https://orcid.org/0000-0002-2677-1028, Mitchell, C, Hider, S ORCID: https://orcid.org/0000-0002-9958-3909, Hill, C, Shea, B and Mackie, S (2020) Outcomes Measured in Polymyalgia Rheumatica and Measurement Properties of Instruments Considered for the OMERACT Core Outcome Set: A Systematic Review. Journal of Rheumatology.

[img]
Preview
Text
jrheum.200248.full.pdf - Accepted Version

Download (2MB) | Preview

Abstract

OBJECTIVE: To systematically identify the outcome measures and instruments used in clinical studies of polymyalgia rheumatica (PMR) and to evaluate evidence about their measurement properties. METHODS: Searches based on the MeSH term 'polymyalgia rheumatica' were carried out in five databases. Two researchers were involved in screening, data extraction and risk of bias assessment. Once outcomes and instruments used were identified and categorised, key instruments were selected for further review through a consensus process. Studies on measurement properties of these instruments were appraised against the COSMIN-OMERACT (Outcome Measures in Rheumatology) checklist to determine the extent of evidence supporting their use in PMR. RESULTS: 46 studies were included. In decreasing order of frequency, the most common outcomes (and instruments) used were: markers of systemic inflammation (ESR/CRP), pain (visual analogue scale (VAS)), stiffness (duration in minutes) and physical function (elevation of upper limbs). Instruments selected for further evaluation were ESR, CRP, pain VAS, morning stiffness duration and Health Assessment Questionnaire. Five studies evaluated measurement properties of these instruments, but none met all of the COSMINOMERACT checklist criteria. CONCLUSION: Measurement of outcomes in studies of PMR lacks consistency. The critical patient-centred domain of physical function is poorly assessed. None of the candidate instruments considered for inclusion in the core outcome set had high quality evidence, derived from populations with PMR, on their full range of measurement properties. Further studies are needed to determine whether these instruments are suitable for inclusion in a Core Outcome Measurement set for PMR.

Item Type: Article
Additional Information: The final version of this article and all relevant information related to it can be found at; https://www.jrheum.org/content/early/2020/07/27/jrheum.200248
Uncontrolled Keywords: polymyalgia rheumatica, outcome measures, systematic review, OMERACT
Subjects: R Medicine > R Medicine (General)
R Medicine > R Medicine (General) > R735 Medical education. Medical schools. Research
R Medicine > RA Public aspects of medicine
R Medicine > RC Internal medicine > RC925 Diseases of the musculoskeletal system
R Medicine > RC Internal medicine > RC927 Rheumatism
Divisions: Faculty of Medicine and Health Sciences > School of Primary, Community and Social Care
Related URLs:
Depositing User: Symplectic
Date Deposited: 17 Aug 2020 08:26
Last Modified: 17 Aug 2020 11:48
URI: https://eprints.keele.ac.uk/id/eprint/8553

Actions (login required)

View Item View Item